NCT01180868已完成不适用
The Biodistribution of 1-L-(2 Deoxy-2,- 18 Fluoroarabinofuranosyl) Cytosine ([18F]L-FAC) in Healthy Subjects and Patients With Cancer, Autoimmune and Inflammatory Diseases
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 1
- 试验地点
- 1
研究概览
简要总结
The purpose of this study is to determine the biodistribution of a new agent 1-L-(2 deoxy-2,-18fluoroarabinofuranosyl) cytosine non-invasively in healthy humans and to evaluate whether it can be used to image cancer, autoimmune disease, and inflammation
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 Years 至 —(Adult, Older Adult)
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •greater than 18 years of age
- •women of childbearing potential will undergo a pregnancy test free of charge
- •patients with hematological malignancies, solid tumors or autoimmune disorders
排除标准
- 未提供
研究者
研究点 (1)
Loading locations...
相似试验
已完成
不适用
The Biodistribution of 1-[2 Deoxy-2, -18 Fluroarabinfuranosyl]Cytosine [18FAC] in Healthy Subjects and Patients With Cancer, Autoimmune/Inflammatory DiseasesInflammationCancerNCT01180907Jonsson Comprehensive Cancer Center10
尚未招募
3 期
18F-2-fluoro-2-deoxy-D-glucose in Positron Emission Tomography Computed TomographyOncology18F-2-fluoro-2-deoxy-D-glucoseAdverse EventSolitary Pulmonary NoduleNCT04615156Eastern Health, Canada10,000
已完成
不适用
18-Fluorothymidine positron emission tomography (18-FLT PET/CT) to assess tumour proliferation during radical radiotherapyLung cancerCancerISRCTN97398362Guy's and St. Thomas' NHS Foundation Trust (UK)20
已完成
1 期
Study of 18F-DCFPyL, a Second Generation Low-molecular Weight PSMA-based PET Radiotracer, in Patients With Prostate CancerMetastatic Prostate CancerNCT02151760Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins37
终止
不适用
Fluorine F 18 FEQA in Patients With Stage III or Stage IV Non-Small Cell Lung Cancer and in Healthy ParticipantsLung CancerNCT00444223Jonsson Comprehensive Cancer Center3
